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Abstract. 
 
The signaling pathways that mediate the 
ability of NGF to support survival of dependent neu-
rons are not yet completely clear. However previous 
work has shown that the c-Jun pathway is activated af-
ter NGF withdrawal, and blocking this pathway blocks 
neuronal cell death. In this paper we show that over-
expression in sympathetic neurons of phosphatidylinos-
itol (PI) 3-kinase or its downstream effector Akt kinase 
blocks cell death after NGF withdrawal, in spite of the 
fact that the c-Jun pathway is activated. Yet, neither the 
PI 3-kinase inhibitor LY294002 nor a dominant nega-
tive PI 3-kinase cause sympathetic neurons to die if 
they are maintained in NGF. Thus, although NGF may 
regulate multiple pathways involved in neuronal sur-
vival, stimulation of the PI 3-kinase pathway is suf-
ficient to allow cells to survive in the absence of this 
factor.
 
N
 
eurons 
 
are critically dependent upon growth fac-
tors during development, and up to 50% of neu-
rons born die by apoptosis during this period.
This process is thought to match the number of neurons to
their targets and allows for plasticity during development
(Oppenheim, 1991). The role of apoptosis in neuronal sur-
vival is not limited to development, however. There is now
increasing evidence that it also plays a role in many neuro-
pathological conditions such as Alzheimer’s disease, Par-
kinson’s disease, Huntington’s disease, and stroke (for re-
view see Thompson, 1995; Choi, 1996; Nicholson, 1996).
Understanding the control of neuronal cell death could
therefore lead to more effective therapies for these disor-
ders.
Growth factors are thought to prevent apoptosis by sig-
naling to effector molecules within the cell, and consider-
able effort has been placed in dissecting these signaling
pathways. In the case of neurons, NGF has been investi-
gated in some depth (see Fantl et al., 1993; Segal and Green-
berg, 1996). The binding of NGF to its high-affinity recep-
tor, TrkA, leads to its dimerization and activation of an
intrinsic kinase domain that autophosphorylates tyrosine
residues within the cytoplasmic domain of the receptor
(Jing et al., 1992). The phosphorylated residues lie within
specific amino acid motifs and act as docking sites for a
number of proteins generally containing an SH2 domain
(Koch et al., 1991; Kaplan and Stephens, 1994). These in-
 
clude proteins that regulate the activity of the p21
 
ras
 
/MAPK
pathway, such as SHC, rasGAP, and Grb2, and proteins
that modulate phosphatidylinositol metabolism, including
phospholipase C-
 
g
 
 (PLC
 
g
 
) and the p85 subunit of phos-
phatidylinositol (PI)
 
1 
 
3-kinase (Soltoff et al., 1992; Ober-
meier et al., 1993, 1994; Stephens et al., 1994; Carter and
Downes, 1995).
The role of an individual pathway in neurons may be
somewhat different to that observed in other cell types.
For example, signaling through ras in neurons leads to dif-
ferentiation and neurite outgrowth, while in fibroblasts it
can lead to proliferation (for review see Wood and Rob-
erts, 1993). Activation of these pathways has been studied
in neurons in a number of ways. Trk mutants in the rat
PC12 cell line have demonstrated that the SHC pathway is
important for neurite outgrowth (Obermeier et al., 1994;
Stephens et al., 1994). In addition, scrape loading of ras
into certain types of neurons promotes their survival after
growth factor withdrawal (Borasio et al., 1989; Downward,
1994; Nobes et al., 1996; Weng et al., 1996), and blocking
antibodies directed against ras inhibit survival in freshly
dissociated rat SCG neurons (Nobes and Tolkovsky,
1995). However, ras does not promote survival in all neu-
ronal cell types (Borasio et al., 1993), and downstream inhi-
bition of this pathway using PD98059, a MAPKK inhibi-
tor, does not result in the death of rat SCG neurons
(Virdee and Tolkovsky, 1996). The ras/MAPK pathway
may signal to multiple pathways that are important in dif-
 
Address all correspondence to Karen Philpott, Eisai London Research
Laboratories Ltd., Bernard Katz Building, University College London,
London WC1E 6BT, United Kingdom. Tel.: (44) 171-388-4746. Fax: (44)
171-413-1121. E-mail: kphilpott@elrl.co.uk
 
1. 
 
Abbreviations used in this paper
 
: CGN, cerebellar granule neurons;
GSK, glycogen synthase kinase; IGF, insulin-like growth factor; PI, phos-
phatidylinositol; SCG, superior cervical ganglion.
  
The Journal of Cell Biology, Volume 139, 1997 810
 
ferentiation and neurite outgrowth or survival, depending
on the type of neuron.
Evidence that PI 3-kinase mediates neurite outgrowth is
somewhat contradictory. Studies using receptor mutants
suggested it is not crucial (Obermeier et al., 1994; Steph-
ens et al., 1994), while those directly analyzing the effect of
PI 3-kinase inhibitors on PC12 cells suggested that it does
indeed play a role (Kimura et al., 1994; Jackson et al., 1996).
More recently, there has been the suggestion that PI 3-kinase
may be critical in the survival of several types of cells, in-
cluding neurons (Scheid et al., 1995; Ernhardt and Cooper,
1996; Minshall et al., 1996; Vemuri and McMorris, 1996).
Yao and Cooper (1995) showed that wortmannin, an irre-
versible inhibitor of PI 3-kinase (Yano et al., 1993; Okada
et al., 1994), caused PC12 cells to die in the presence of NGF.
This is supported by the observation that PC12 cells trans-
fected with receptor chimeras containing the extracellular
domain of the PDGF receptor and mutated cytoplasmic
domains were able to survive in the presence of PDGF,
but only when the PI 3-kinase binding site was intact.
Downstream effectors of PI 3-kinase have recently been
described. Akt (also called RAC a or PKB kinase) is a
protein kinase with homology to protein kinases A and C
within the catalytic domain and is the cellular homologue
of vAkt (Bellacosa et al., 1991; Coffer and Woodgett, 1991;
Jones et al., 1991). Akt has been shown to be activated by the
phosphatidylinositol products of PI 3-kinase, and its acti-
vation can be prevented by inhibition of PI 3-kinase (Bur-
gering and Coffer, 1995; Franke et al., 1995; Park et al.,
1996). Recently Akt kinase has been shown to promote
survival in cerebellar granule neurons under certain cir-
cumstances and to protect against c-myc–induced fibro-
blast cell death (Dudek et al., 1997; Kauffmann-Zeh et al.,
1997). It is also known that p70
 
S6
 
 kinase, which lies down-
stream of PI 3-kinase, plays a significant role during mito-
genesis (Downward 1994; Chou and Blenis, 1995; Weng
et al., 1995) but does not appear to be involved in survival
mechanisms (Yao and Cooper, 1996).
We wished to examine the effects of PI 3-kinase and of
downstream effectors on the survival of NGF-dependent
superior cervical ganglion (SCG) neurons. We have found
that although inhibition of PI 3-kinase does not induce apop-
tosis of neurons maintained in NGF, both activated PI
3-kinase and Akt can prevent the death of these cells after
NGF withdrawal. In addition we have examined the effect
of PI 3-kinase on the transcription factor c-Jun, which is
activated in the absence of NGF and which we and others
have previously postulated to play a role in apoptosis (Es-
tus et al., 1994; Ham et al., 1995). We show that PI 3-kinase
does not interfere with the changes in expression of c-Jun
seen upon induction of apoptosis in SCG neurons; there-
fore, PI 3-kinase must be either acting downstream or in-
dependently of c-Jun. We conclude that NGF activates
multiple signaling pathways and that stimulation of PI
3-kinase is sufficient, but not obligatory, for the survival of
SCG neurons.
 
Materials and Methods
 
Cell Culture
 
SCG neurons were removed from newborn rat pups and dissociated in
 
0.025% trypsin for 30 min after which an equal volume of 0.4% collage-
nase (Worthington, Reading, UK) was added for a further 30 min. The
cells were triturated with a 19-gauge needle until a single cell suspension
was obtained and preplated for 2 h to allow non-neuronal cells to attach
(Deckwerth and Johnson, 1993). The neurons were gently rinsed off, cen-
trifuged, and resuspended in culture medium. Neurons were plated on
poly-
 
l
 
-lysine/laminin–coated 13-mm glass coverslips at 8 
 
3
 
 10
 
3
 
 cells/cov-
erslip. The cell culture medium was DME (GIBCO BRL Laboratories,
Paisley, UK) containing 10% fetal calf serum (Globepharm Limited, Sur-
rey, UK), 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, 2 mM glutamine,
and 100 ng/ml NGF (Promega, Southampton, UK). To limit the growth of
any contaminating non-neuronal cells, 20 
 
m
 
M fluorodeoxyuridine, and
20 
 
m
 
M uridine (Sigma Chemical Co., Dorset, UK) were added. Cells were
cultured for 5 to 8 d before use in a humidified 10% CO
 
2
 
 incubator at
37
 
8
 
C.
 
Microinjection
 
Microinjection was carried out using a microscope (Axiovert 135M; Zeiss,
Inc., Thornwood, NY) with an Eppendorf transjector (model 517; Camp-
den Instruments, Leicester, UK) and micromanipulator (model 5246;
Campden Instruments). Microinjection needles were pulled from glass
capillaries using a horizontal electrode puller (model 773; Campden In-
struments). DNA was injected into the nucleus in 0.5
 
3
 
 PBS with either 5
 
m
 
g/ml of purified guinea pig IgG (Sigma Chemical Co.) for cell staining
experiments or 5 
 
m
 
g/ml of neutral 70 kD Texas red dextran (Molecular
Probes, Eugene, OR) for cell survival experiments. We found some pro-
tective effect (
 
z
 
20%) due to injection of plasmid DNA and Texas red
dextran and therefore used equivalent DNA concentrations in all microin-
jection experiments.
 
Survival Assays
 
After microinjection, cells were left 4–24 h to allow the protein to be ex-
pressed, and the number of Texas red dextran-positive cells was then
counted (100% value). The cells were washed twice with DME and fresh
medium lacking NGF but containing 100 ng/ml of anti-NGF antibody
(Boehringer Mannheim, East-Sussex, UK). After 72 h the cells were incu-
bated for 30 min with 1 
 
m
 
M calcein AM, which is converted to a green flu-
orescent derivative in live cells (Live/Dead kit; Molecular Probes). Cells
that were positive for both Texas red dextran and calcein were counted as
viable. In experiments that did not involve microinjection, calcein-positive
cells in 10 random fields around the perimeter of the coverslip were
counted at a magnification of 200. All experiments were done in a blinded
manner.
In experiments in which LY294002 (Affiniti Research Products Ltd.,
Nottingham, UK) was used, 0.6% methyl cellulose was added to the me-
dium to prevent cells from mechanically detaching (Hawrot and Patter-
son, 1979). Rapamycin was purchased from Calbiochem-Novochem (Not-
tingham, UK).
 
Immunofluorescence
 
When analyzing the protein expression of plasmid-injected neurons, puri-
fied guinea pig IgG was co-injected. The cells were injected and stained 24 h
later unless stated otherwise. Cells were generally fixed in 3% paraformal-
dehyde for 20 min, permeabilized for 5 min in 0.5% Triton X-100, and
blocked in 50% goat serum/50% antibody diluting buffer (1% BSA in
PBS) for 30 min. Cells were incubated with primary antibodies for 1 h at
room temperature, rinsed, and incubated in FITC-conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) plus
rhodamine-conjugated donkey anti–guinea pig IgG for a further 30 min.
Cells were costained with 1 
 
m
 
g/ml of Hoechst 33342 for 5 min before
mounting in Citifluor (Citifluor Ltd., Canterbury, UK). Primary antibod-
ies included an anti–c-Jun antibody, raised against a gst–c-Jun fusion pro-
tein, an anti–phospho-c-Jun monoclonal antibody raised against the phos-
phopeptide amino acids 57–68 (phospho-serine 63) from the mouse c-Jun
sequence, both provided by Dominique Lallemand (Pasteur Institute, Paris,
France), an anti-p85 antibody, a gift from Ivor Gout (Ludwig Institute,
London, UK), and an anti-myc antibody (9E10; Boehringer Mannheim).
In the case of the anti–c-myc antibody, cells were fixed in 50% methanol/
50% acetone and subsequently processed as above. Photographs of cells
were taken on a fluorescent microscope (Microphot-FXA; Nikon) using
Kodak 400 ASA film. 
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Constructs
 
The PI 3-kinase plasmids used in this paper were p110* PI 3-K (constitu-
tively active kinase) and p110*
 
D
 
 PI 3-kinase (kinase dead construct) and
have been previously described (Hu et al., 1995). The wild-type, K179M,
and viral Akt constructs were supplied by Dr. Philip Tschillis (Fox Chase
Cancer Center, Philadelphia, PA); the p85 construct was obtained from
Dr. Len Stephens (Babraham Institute, Cambridge, UK) with the permis-
sion of Professor Kasuga (Kobe University School of Medicine, Kobe, Ja-
pan), and the 
 
D
 
169 c-Jun and pCDbcl-2 plasmids were obtained from Dr.
John Ham (Eisai Laboratories, London, UK).
 
Results
 
Inhibition of PI 3-Kinase Does Not Kill SCGs in the 
Presence of NGF
 
To determine the effects of inhibiting PI 3-kinase in pri-
mary neurons, we incubated cells in 50 
 
m
 
M LY294002 for 3 d
in the presence of NGF. We had found that this concen-
tration of LY294002 inhibited neurite outgrowth in newly
plated cells (data not shown). However we could detect no
decrease in the survival of differentiated cells, using the
Live/Dead assay after 72 h incubation in LY294002 (Fig.
 
1 
 
A
 
). We did not use wortmannin in these experiments
since it has a half-life of 
 
z
 
3 h. The gross morphology of
cells grown in LY294002 appeared normal (Fig. 1 
 
B
 
), but
they appeared slightly smaller, perhaps due to their de-
creased substrate attachment, which is consistent with a
postulated role of PI 3-kinase in substrate adhesion (Serve
et al., 1995).
As an alternative method for inhibiting the action of PI
3-kinase, we microinjected a dominant negative p85 con-
struct. The canonical PI 3-kinase consists of a p110 cata-
lytic subunit and a p85 regulatory unit which is important
for receptor binding and interacting with other cellular pro-
teins (Carpenter and Cantley, 1996). The dominant nega-
tive p85 lacks a 35-amino acid stretch within the inter-SH2
domain necessary for p110 binding and is able to bind to
the TrkA receptor, but not to the PI 3-kinase p110 subunit
(Hara et al., 1994). We found this modified p85 to be ex-
pressed throughout the cytoplasm (Fig. 2 
 
A
 
), but it did not
induce apoptosis in SCG neurons in the presence of NGF
(Fig. 2 
 
B
 
), even though it has been reported to block neu-
rite outgrowth in NGF-stimulated PC12 cells (Jackson et al.,
1996). These data indicate that the activity of PI 3-kinase is
not essential for survival when cells are maintained in NGF.
 
Constitutively Active PI 3-Kinase Protects SCG 
Neurons from NGF Withdrawal-Induced Death
 
A constitutively active myc-tagged version of PI 3-kinase
(p110*), containing the p110 kinase subunit linked to the
inter-SH2 domain of the p85 subunit (Hu et al., 1995),
was used in these experiments. Expression of this protein
was verified by staining with an anti-myc–tagged antibody
(9E10), as shown in Fig. 3 
 
A.
 
 For survival experiments,
DNA was microinjected into 5- to 8-d-old neurons and the
neurons withdrawn from NGF 16–24 h later, having al-
lowed sufficient time for the protein to be expressed. After
an additional 72 h, survival was quantified. Three control
plasmids were used: pCD
 
bcl-2
 
, known to enhance SCG
survival after NGF withdrawal (Garcia et al., 1992; Ham et
al., 1995); the backbone vector pCG; and a kinase-dead
version of PI 3-kinase, p110*
 
D
 
, in which amino acids 917–
950 of wild-type p110 had been removed. PI 3-kinase dis-
played a striking ability to support survival of NGF-deprived
neurons, being approximately as effective as bcl-2. On the
other hand, the kinase-dead variant was completely inef-
fective (Fig. 3 
 
B
 
). If we were indeed promoting survival by
introducing activated PI 3-kinase, this effect should be
completely reversed by the addition of the PI 3-kinase in-
hibitor, LY294002. As expected, when added at the time
of NGF removal, LY294002 did block the protective ef-
fects of PI 3-kinase (Fig. 4). Hence our results indicate
that, in the absence of NGF, expression of PI 3-kinase ac-
tivity is sufficient to prevent apoptosis.
 
The Kinase Akt Promotes Survival of SCG Neurons
 
One of the kinases known to lie downstream of PI 3-kinase
is Akt, which can be directly activated by products of PI
3-kinase (Franke et al., 1995, 1997). We injected wild-type
(wt), viral (v) Akt, or a kinase-dead version, Akt K179M,
into 5- to 8-d-old SCG neurons and confirmed that wtAkt
and K179M Akt were expressed using an anti-HA anti-
body to the 3
 
9
 
 tag (data not shown). We found that wtAkt
Figure 1. LY294002 does not kill SCG neurons maintained in
NGF. Cells were treated with or without 50 mM LY294002 in the
presence of NGF for 3 d. (A) Results are the mean 6 SEM from
three experiments. (B) Cells were maintained in NGF (a and b),
NGF deprived (c and d), or maintained in NGF in the presence of
50 mM LY294002 (e and f) for 3 d. Phase micrographs are shown
in a, c, and e, and Hoechst-stained cells are shown in b, d, and f.
Bar, 30 mm. 
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or vAkt maintained survival of SCG neurons withdrawn
from NGF but that K179M Akt did not (Fig. 4). To ascertain
whether the protection by Akt was specific to the PI 3-kinase
pathway, we treated injected cells with LY294002. LY294002
prevented protection by injected PI 3-kinase (Fig. 4) but
did not prevent survival promoted by the Akt constructs.
p70
 
S6
 
 kinase is known to lie downstream of PI 3-kinase
and can be inhibited by the macrolide antibiotic rapamycin
(Chung et al., 1992; Price et al., 1992; Soltoff et al., 1992).
Rapamycin did not induce neuronal apoptosis when cells
were maintained in NGF (data not shown) and did not in-
hibit the survival-promoting effect of Akt (Fig. 4).
 
PI 3-Kinase Does Not Inhibit Increased c-Jun 
Expression or Phosphorylation after NGF Withdrawal
 
We have previously shown that after the withdrawal of
NGF from neurons there is a marked increase in the ex-
pression and phosphorylation of the transcription factor
c-Jun (Ham et al., 1995; A. Watson, personal communica-
tion). This increase in expression and phosphorylation can
be inhibited by a dominant negative form of c-Jun, 
 
D
 
169
c-Jun, in which the transactivation domain has been de-
leted. This mutant can also protect the cells from apoptosis.
We have therefore postulated that c-Jun plays an impor-
tant role in the death process in neurons by initiating the
transcription of genes essential for their death. To deter-
mine, therefore, whether the survival-promoting activity
of PI 3-kinase could act by inhibiting the c-Jun pathway,
we injected neurons with either activated PI 3-kinase, a
vector control, or 
 
D
 
169 c-Jun. NGF was withdrawn 16–24 h
later and the cells stained for either c-Jun or phospho–c-Jun
expression after an additional 24 h. The phospho–c-Jun
antibody used was raised against a peptide containing
phosphorylated serine 63 in the c-Jun sequence, a site
known to be phosphorylated in activated c-Jun (Smeal et
al., 1991). Activated PI 3-kinase was unable to inhibit ei-
ther the increase in nuclear staining of c-Jun or of phos-
phorylated c-Jun that follows NGF withdrawal. However,
 
D
 
169 c-Jun prevented both changes as expected (Fig. 5,
 
A–C
 
). This suggests that PI 3-kinase is acting downstream
of c-Jun or independently of it, and that apoptosis can be
prevented even when c-Jun has been activated.
 
Discussion
 
Recently there have been a number of reports examining
the effects of PI 3-kinase inhibition on cell survival. These
have included studies on cells of hemopoeitic origin that
were maintained with different survival factors. It was
Figure 3. Activated PI 3-kinase protects SCG neurons from NGF
withdrawal-induced death. (A) Cells were injected with 100 ng/ml
of activated PI 3-kinase vector and stained 24 h later for the myc-
tag epitope present on the PI 3-kinase construct (a), guinea pig
IgG (b), and Hoechst (c). (B) 200 cells were injected per cover-
slip with 100 ng/ml of plasmid DNA and scored for survival 3 d
later. Results are the mean of six experiments (five for Bcl-2) 6
SEM. Bar, 20 mm.
Figure 2. A dominant negative PI 3-kinase construct, Dp85, does
not induce SCG neuron death. (A) Cells were microinjected and
stained 24 h later for p85 (a), for guinea pig IgG (b), and Hoechst
(c). (B) 200 cells/coverslip were injected with 100 ng/ml of either
Dp85 or pCG. Cells were scored after 3 d for survival in the pres-
ence of NGF. Results are the mean of three independent experi-
ments 6 SEM. Bar, 20 mm. 
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noted that PI 3-kinase was important for survival of MC-9
cells when they were grown in IL-3 or -4, but not when
they were grown in GMCSF or IL-5 (Scheid et al., 1995).
However, other types of hemopoeitic cells were depen-
dent on PI 3-kinase for survival when they were main-
tained in IGF-1, but not in IL-3 (Minshall et al., 1996).
Further, the survival of other types of cells, such as oligo-
dendrocytes and fibroblasts, seems to be mediated by PI
3-kinase under all growth conditions (Vemuri and McMor-
ris, 1996; Yao and Cooper, 1996). PI 3-kinase activity has
also been shown to be important in the survival of PC12
cells, a model system for sympathetic neurons (Rukenstein
et al., 1991; Yao and Cooper, 1995), and most recently in
cerebellar granule neurons grown in IGF-1 (Dudek et al.,
1997). Thus it seems that multiple survival pathways ac-
cessed via different receptors are often present within cells
and that their dependence upon PI 3-kinase cannot neces-
sarily be predicted by the use of a particular survival agent.
To investigate the role of PI 3-kinase in a more physio-
logically relevant system than PC12 cells, we chose to study
NGF-dependent SCG neurons, primary sympathetic neu-
rons. PI 3-kinase activity can be inhibited in a number of
ways, and we used two different methods. The first was the
PI 3-kinase inhibitor LY294002, a reversible inhibitor that
competes with ATP for binding to the enzyme (Vlahos et al.,
1994). Addition of LY294002 to neurons did not induce
apoptosis (Fig. 1), although this compound effectively in-
hibited PI 3-kinase, since it blocked the effects of over-
expressed enzymatically active kinase (Fig. 4, and below).
We also employed an alternative way of inhibiting PI 3-kinase
by microinjecting a dominant negative form of p85. This
construct lacks the region necessary for binding to the
p110 subunit while retaining its ability to interact with the
receptor or other docking molecules (Klippel et al., 1993;
Hara et al., 1994). It is thus able to block endogenous PI
3-kinase activity. It has been shown to effectively inhibit PI
3-kinase in a number of cell types including CHO cells stim-
ulated with insulin or EGF (Hara et al., 1994; Kido et al.,
1995) and it inhibits NGF-induced neurite outgrowth in
PC12 cells (Jackson et al., 1996). Dominant negative p85 also
did not induce apoptosis in SCG neurons grown in NGF
(Fig. 2 
 
B
 
) which, together with the inhibitor data, indicates
that in the presence of NGF, PI 3-kinase activity is not
necessary for survival of SCG neurons. This is in contrast
to the results obtained with PC12 cells (Yao and Cooper,
1995), where PI 3-kinase inhibitors induced death, and
highlights the importance of using primary cells.
We also studied the effects of over-expression of acti-
vated PI 3-kinase on the survival of NGF-deprived neu-
Figure 5. Activated PI 3-kinase does not affect the expression of
c-Jun after NGF withdrawal. Cells were injected with activated
PI 3-kinase, pCG, or D169 c-Jun. After 16–24 h they were with-
drawn from NGF, fixed 24 h later, and stained for c-Jun (A) or
phospho-c-Jun (B and C). The graphs in A and B represent data
from three independent experiments each, in which 200 cells
were injected per coverslip and scored positive for c-Jun or phos-
pho-c-Jun if there was increased staining in the nucleus. (C) In-
jected cells were withdrawn from NGF (a–i) or maintained in
NGF (j–l). Cells were injected with PI 3-kinase (a–c), pCG (d–f,
and j–l), or D169 c-Jun (g–i). Cells were stained for phospho-c-Jun
(a, d, g, and j), for guinea pig IgG (b, e, h, and k), or with Hoechst
(c, f, i, and l). Bar, 20 mm.
Figure 4. Akt Kinase protects SCG neurons from NGF with-
drawal-induced death. 200 cells/coverslip were microinjected
with plasmid DNA at 100 ng/ml, withdrawn from NGF 16–24 h
later, and treated with no compound or with 10 mM LY294002
(LY) or 2 nM rapamycin (Rap) as indicated. Results are the
mean of three experiments 6 SEM.The Journal of Cell Biology, Volume 139, 1997 814
rons. Surprisingly, this enzyme was effective in enhancing
survival (Fig. 3 B). The enzymatic activity of this kinase
was necessary, since the activated PI 3-kinase did not pro-
mote survival if cells were maintained in the presence of
LY294002 and since a kinase-dead version of the construct
did not promote survival (Figs. 3 and 4).
More recently, Akt kinase (Bellacosa et al., 1991; Coffer
and Woodgett, 1991; Jones et al., 1991) has been shown to
be stimulated by the products of PI 3-kinase (Franke et al.,
1995, 1997; Klippel et al., 1997) after activation of receptor
tyrosine kinases. When expressed in SCG neurons, wtAkt
and vAkt were both protective after NGF withdrawal.
Franke et al. (1995) found a low level of Akt kinase activ-
ity in the absence of PDGF after transfection with wtAkt
into NIH 3T3 cells. Perhaps even in the absence of NGF
there is sufficient PI 3-kinase activity to stimulate wtAkt
kinase when Akt protein levels are high. Alternatively,
overexpression of the protein could lead to an increase in
membrane-localized Akt, which may lead to enhanced ac-
tivity (Ahmed et al., 1993; Kulik et al., 1997). Interestingly,
we find that K179MAkt, which has been shown to act as a
dominant negative protein (Dudek et al., 1997), does not
induce apoptosis in the presence of NGF, again suggesting
that this pathway is not obligatory in the presence of NGF.
Dudek et al. (1997) have carried out experiments on cer-
ebellar granule neurons (CGN) whose survival in serum-
free, low K1 medium could be partially supported by insu-
lin-like growth factor 1 (IGF-1). LY294002 treatment of
these neurons resulted in their death, suggesting that IGF-1
conferred protection via PI 3-kinase signaling. Transfec-
tion of CGN with Akt kinase expression vectors promoted
their survival in the absence of IGF-1, suggesting that Akt
kinase was important in the survival mediated by this growth
factor. However, analogous to the situation we describe
with NGF and SCG neurons, PI 3-kinase was not an oblig-
atory survival pathway when cells were grown in serum
plus high K1. Since the submission of this paper, Miller et al.
(1997) have also described survival mediated by PI 3-kinase
in CGN, maintained in IGF-1 or by depolarization in low
serum (Miller et al., 1997).
We also investigated the effect on survival of p70S6 ki-
nase thought to be downstream of PI 3-kinase and Akt ki-
nase (Downward, 1994). Rapamycin, a potent inhibitor of
p70S6 kinase activation (Price et al., 1992), did not induce
apoptosis itself and did not inhibit the survival-promoting
action of Akt kinase. Thus our results suggest that in SCG
neurons PI 3-kinase signals downstream to Akt kinase and
that Akt kinase is not working via p70S6 kinase. It is un-
clear what molecules Akt is signaling to in these neurons.
A known substrate for Akt is glycogen synthase kinase 3
(GSK3), which is inhibited upon phosphorylation by Akt.
GSK3 was initially described as negatively regulating gly-
cogen synthase, the rate-limiting enzyme in glycogen syn-
thesis, but is now known to phosphorylate many other pro-
teins (Welsh et al., 1996), and it may be the case that
molecules downstream of GSK3 play a role in apoptosis.
To investigate further how PI 3-kinase can inhibit death,
we also looked at the level and phosphorylation state of
the transcription factor c-Jun. We had previously shown that
upon the withdrawal of NGF from SCG neurons, c-Jun in-
creases in level and becomes phosphorylated, leading to its
activation (Ham et al., 1995; A. Watson, personal commun-
ication). In addition, the c-Jun NH2-terminal protein ki-
nase (JNK) pathway had been implicated in apoptosis of
PC12 cells (Xia et al., 1995). We therefore examined by
immunofluorescence the level of c-Jun and of phospho–c-Jun
in cells microinjected with activated PI 3-kinase. PI 3-kinase
did not prevent the accumulation of nuclear c-Jun or phos-
pho–c-Jun in neurons after NGF withdrawal (Fig. 5). This
suggests that PI 3-kinase is acting to inhibit the death path-
way downstream of c-Jun or independently of it. PI 3-kinase
did not induce c-Jun expression itself when injected in the
presence of NGF (data not shown). Importantly, these
data also indicate that the kinases involved in c-Jun regu-
lation, such as JNK, are not directly affected by the PI
3-kinase pathway, since phosphorylation of c-Jun followed
the normal pattern after NGF withdrawal. It is possible
therefore that PI 3-kinase is a cytoplasmic survival effector
that is able to mediate NGF-induced survival indepen-
dently of new transcription or protein synthesis.
In summary, we have demonstrated a potential role for
PI 3-kinase and Akt kinase in the survival of SCG neurons
after NGF withdrawal. Since inhibition of PI 3-kinase does
not induce apoptosis in the presence of NGF, it is likely
that there are other survival pathways stimulated by NGF.
In addition we have shown that the protective effect of PI
3-kinase is not due to prevention of c-Jun activation. Stim-
ulation of the PI 3-kinase pathway, with its survival-pro-
moting effects, could therefore lead to novel therapies for
a range of degenerative disorders associated with neuronal
apoptosis.
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